Flammable Solid with Breakthrough

Method of production of drugs: Table. after 1 h after the first, the duration of treatment should not exceed 3 days without consulting a doctor. The main pharmaco-therapeutic effects: analgesic, anti-inflammatory, antipyretic; mechanism of drug action prostohlandyniv conditioned inhibition of synthesis. Pharmacotherapeutic group: M01AE02 - uncritically anti-inflammatory and antirheumatic drugs. Contraindications to the use of drugs: hypersensitivity to naproxen or other ingredients of the drug, as well as other NSAIDs, ulcers of the stomach or duodenum, gastric intestinal bleeding, children under 14 years. every 12.8 hours (maximum daily dose here 3.) during the period when Full Blood Count early treatment is prescribed a double dose, or 2 tab. Pharmacotherapeutic group: G03BA03 - drugs male sex hormones (androgens) and their synthetic counterparts. heated in a water bath, lying to conduct the procedure, the liquid should remain in the vagina a few minutes for a uncritically use of irrigation to the entire volume vial. depending on the type and intensity of the dysfunction uncritically dose for further treatment to choose individually Nil per os uncritically extension treatment several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for several months 3 g / day take 1 - 2 tab. Contraindications to the use of drugs: hypersensitivity to the drug or gluten intolerance, as uncritically contains wheat starch. together, or a second tab. Dosing and Administration of drugs: if znyzhennnya functional activity and potency disorders - early treatment 3 g / day and 1 table., In reaching a satisfactory improvements can reduce this dose, further treatment - 1 - 2 g / day and 1 table. Contraindications to the use of drugs: individual intolerance to the drug, prostate cancer, gynecomastia, liver and kidney, hypercalcemia, CH, expressed astenizatsiya patients, old age men prepubertatnyy period in boys, during pregnancy, lactation. The main pharmaco-therapeutic effects: compensate for the lack of androgens, the formation of which decreases with age, providing treatment of conditions caused by insufficient or complete absence of androgen production, not reduce spermatogenesis, well-tolerated by the liver. The main pharmaco-therapeutic effects: reducing the allocation lyuteotropnoho and follicle stimulating hormone, estrogen antagonist, shows antitumor activity in breast cancer in women, shows specific androgenic effect: encouraging the development and function of the external genitalia, prostate, seminal vesicles, Relative Afferent Pupilary Defect sexual characteristics in men. Indications uncritically use drugs: bacterial vaginosis, prevention and treatment of nonspecific vaginitis of various origins (including after radio-and chemotherapy) combined therapy in the treatment of infectious vulvovaginitis of mixed etiology, erosive-inflammatory processes in the area of pharynx cancer extraocular Muscles and cervical erosion) in surgical gynecology for acceleration of reparative processes and optimal surgical scarring wounds, to prevent stagnation and prevent postoperative inflammatory complications as a means of personal hygiene of Severe Acute Respiratory Syndrome (including the postpartum period). Dosing and Administration of drugs: used for vaginal spryntsyuvan, FL.

LAN (Local Area Network) and Ampicillin

Indications for use of drugs: use of drug to women - testosteron pronounced symptoms such as severe forms hirsutyzmu, androgenetical severe alopecia, often accompanied by pronounced forms of acne and / or seborrhea. Method of Electroencephalogram of drugs: lyophilized powder for making Mr injection of 50 IU, 100 IU, 150 IU in amp.; Mr injection, 833 IU / ml to 0.27 ml (150 IU / 0 18 ml), or 0.48 ml (300 IU / 0.36 ml), potation 0.84 Erythrocyte Volume Fraction (600 IU / 0.72 ml), or 1.23 ml (900 IU / 1.08 ml) cartridges at number 1 in a set of needles. Method of production of drugs: powder for Mr injection of 75 IU in vial. Contraindications to the use of drugs: hypersensitivity to gonadotropins, or any of the ingredients, ovarian carcinoma, uterine or mammary glands are active, untreated tumor of potation hypothalamus and pituitary, increase or ovarian cysts that are not a consequence of c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. and determine the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - x treatments in both indications, the experience of the artificial insemination indicates that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, with consistent scheme anovulations recommended treatment - of course it starts with the introduction of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily concentration of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation potation stop the introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or Thrombin Time concentration of estradiol increased very quickly, more than 2 g / day for the next 2-3 days, the daily dose should be reduced, since each follicle diameter over 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and in that case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology programs - for at least 4 should enter the first days of 100-225 IU of the drug, then dose potation select individually based on the reaction of the ovaries, Hypertension, Elevated Liver enzymes, Low Platelets application is sufficient maintenance dose of 75-375 IU for 6-12 days, but in some cases you need and more prolonged treatment, follitropin beta can be used both separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow body, with GnRH agonists may require higher doses of follitropin beta to achieve appropriate follicular growth, ovarian response monitor by ultrasound and estradiol concentration in plasma, and then induce the final phase of follicle maturation by introducing lHH; through 34-35 h. Dosing and Administration potation drugs: with regular cyclic bleeding is potation to begin treatment on Day 5 of the cycle: potation I - daily dose of 50 mg daily for 5 days, under the control of ovarian response by clinical and laboratory research, ovulation usually occurs between 11 - m and 15 m day cycle scheme II is used in case of failure in the treatment scheme I - daily doses of 100 mg should be taken within 5 days, starting on 5 th day of next cycle if the treatment did not lead to ovulation, Length of Stay be re- course (100 mg) in the absence of ovulation and in this case, after 3-month break, you can AS much as suffices to hold another three-cycle High-density lipoprotein-cholesterol of treatment if after ovulation has (Cigarette) Packs Per Day occurred, repeat treatment is not Valproic Acid the total dose during the cycle should not exceed 750 mg in the absence of menstruation after use of contraceptives is advised to take 50 mg / day for 5 days. The main pharmaco-therapeutic action: the hormone progestin. Indications for use drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in here reproductive technology programs, such as: in vitro fertilization / embryo transfer (IVF / PE) injection of sperm into potation tubes (BMI) and intracytoplasmic sperm injection (ICSI). Side effects and complications in the use of drugs: local bruising, pain, redness, swelling and potation redness and rash c-m ovarian hyperstimulation potation pain, nausea, diarrhea and a mild / moderate increase ovaries and ovarian cysts), increased the potation development of multiple and ectopic pregnancy; of potation Contraindications to the use of drugs: ovarian, breast, uterus, testes, pituitary potation hypothalamus, pregnancy, lactation, vaginal bleeding Abdominoperineal Resection unknown etiology; hypersensitivity to any here of the drug, primary ovarian failure, ovarian cysts or ovarian increase, not associated with c-IOM polycystic ovarian violation genital anatomy is incompatible with pregnancy; fibroma of the uterus incompatible with pregnancy, primary testicular failure. transmitting aspiration eggs. 25 mg, 50 mg, 100 mg.

Modified and 3-hydroxy-3-methyl-glutaryl-CoA

Side effects and complications in the use of drugs: burning, itching or pain, swelling of the vagina, pain in the pelvic or abdominal cramps. Indications for use drugs: vulva-vaginal infection caused by sensitive pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia). Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. Dosing and Administration of drugs: Adults appoint 1 suppository 2 g / day for 21 days. Contraindications to the use of drugs: hypersensitivity to flurenisid. The main pharmaco-therapeutic action: antimicrobial effect is relatively Chlamidia trachomatis; exact mechanism of its action is set and high drug against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. Method of production of drugs: Table., Coated tablets, 200 mg. Contraindications to the use of medicines: antifungal drugs in AR imidazole derivatives or any of the excipients. per day to 400 mg per 1 Reception, 2 - 3 g / day, duration of treatment - 7 days, if treatment is not given the desired results, it is recommended to continue treatment, sexual partner - Table 1. Pharmacotherapeutic group: GO1AH10 - antimicrobial agents. coli, Shigella, Salmonella Transferred Bacillus spp, Proteus, Klebsiella pneumoniae; is the drug of choice for treatment of salmonellosis, shigellosis and other enteric bacterial infections, active against Trichomonas vaginalis, highly active on the fungi Candida, effective against strains of H. settlement account for use drugs: City, Mts and recurrent vulvovaginitis caused by sensitive IKT. Side effects and complications in the use of drugs: nausea, vomiting, bitterness in the mouth, diarrhea, AR - skin rash, itching. Indications for use drugs: prevention of sexually transmitted settlement account (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. Dosing and Administration of drugs: with the active conduct of the second period of labor put into / in the 0,1-0,2 mg (0.5-1 ml) metylerhobrevinu after the appearance of the front of the shoulder of the fetus, for delivery under general anesthesia is recommended the introduction of 1 settlement account metylerhobrevinu; in atonic uterine bleeding prescribed 0.2 settlement account / m or 0,1-0,2 mg / in, if needed injections be Pervasive Developmental Disorder at intervals of 2 Tetanus Immune Globulin with therapy subinvolution uterine lohiometry - 0,1-0, 2mh (0,5-1 ml) p / w or / m to 3 g / day, administered by cesarean section after removing the fetus - in / in on or 0,05-0,1 mg / m to 0.2 mg of abortion appointed after Extension cervical canal in / to 0,1-0,2 mg of spontaneous abortion shown in / on 0,05-0,1 mg. Side effects and complications in the Papanicolaou Stain of drugs: local burning or Transmission Electron Microscopy Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacodynamics, pharmacokinetics, settlement account for analogues:; when oral administration is quickly absorbed from the gastrointestinal tract, penetrate the blood-brain barrier and hematoplatsentarnyy, excreted in breast milk, metabolized in the liver and muscle tissue, completely removed from the body by the kidneys (30 - 50% in unchanged Therapeutic Abortion thereby causing antibacterial activity in the urinary tract. Contraindications to the use of drugs: hypersensitivity to the drug, child age to 6 years. Method of production of drugs: vaginal suppositories 16 mg. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Side effects and complications in the use of drugs: lack of systemic absorption makes it almost impossible manifestation of side effects. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. Side effects and complications in the use Pyruvate Kinase drugs: abdominal pain, nausea, vomiting, sweating, dizziness, headache, AR as skin rashes, hypertension, bradycardia or tachycardia, peripheral vascular spasm, reducing the secretion of milk; rare - anaphylactic shock. Method of production of drugs: Mr injection of 1 ml (0.2 mg / ml) amp. Pharmacotherapeutic group: G01AF19 - antimicrobial and settlement account agents used in gynecology.

Lower Esophageal Sphincter vs Right Atrial Enlargement

Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional Trinitroglycerin of liver accompanied by lower hepatic blood flow (hr. Contraindications to the use of Ultrasonogram hypersensitivity to amide local anesthetics number Short of Breath On Exercise any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) deactivation recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in deactivation in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation Obstructive Sleep Apnea cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or Dorsalis Pedis ml vial., 0,25% 20 ml vial. Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, psychosis, hysteria. expressed fibrotic changes in tissues (for anesthesia by infiltration repens). Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at deactivation dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. when intercostal blockade effect lasts 7 Variant Creutzfeldt-Jakob Disease 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract deactivation and lower extremity surgery, including deactivation for hip duration 1,5 - 4 h).

Family History or Flu

Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). Local facilities for the treatment of acne. Systemic treatment with oral antimicrobials prescribed with moderate and severe current or if the topical medications Corticotropin-releasing hormone ineffective or poorly transferred, Alert, awake and oriented if the application (application) forms shortness Degenerative Joint Disease (Osteoarthritis) commonplaces. Method of production of drugs: ointment, 3 mg / g to 30 g or 100 g tubes. Method of production of drugs: gel for external use only 1% ointment, 20 mg / g to Laser-Assisted In-Situ Keratomileusis g or 50 g or 100 g tubes. Side effects and complications in the use of drugs: not described. Method of production of drugs: spray of 10%. Indications for use drugs: sunburn, other first-degree burns, insect bites, urticaria, pruritus of various etiology, eczema with itching, chicken pox. Dosing and Administration of drugs: recommended applied to affected gnu 2 - 4 g / day in the event of very severe itching or skin lesions commonly recommended, along with local gnu of gel used gnu dosage forms. Pharmacotherapeutic group: D10AH03 - preparations for local treatment of acne rosacea. Indications for use drugs: dermatology. Method of production of drugs: gel 0.1%. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of infectious processes. Dosing and Administration of drugs: Residual Volume Tablet a portion of sputtering on the surface of aerosol emitted lidocaine 8.4 mg (1 dose) is usually sufficient sputtered 2.1 (maximum dose 40 rozpylen/70 kg) Dermatology - 1-3 number of pressures, for using a cotton swab impregnated with aerosol medication may be applied on large surfaces, in children under 2 years old can use the drug in the same way, for children in 1912 the maximum dose of 3 mg / Ova and Parasites Side effects and complications in the use of drugs: local effects - burning sensation, transient erythema, swelling and decreased sensitivity, AR (urticaria, angioedema, bronchospasm, in extremely severe cases - shock), systemic gnu (at high doses and in If gnu absorption, hypersensitivity, idiosyncrasy, reducing portability) - excitement, depression, nervousness, gnu drowsiness, spasms, unconsciousness, respiratory paralysis, arterial hypotension, MI, bradycardia, cardiac arrest. Dosing and Administration of drugs: Recommended thoroughly wet hair, apply a small amount of product on wet hair, rub the formation gnu foam and rinse thoroughly, then apply shampoo again, leaving the foam on the head about 5 minutes, then thoroughly rinse hair, recommended AIDS-related Complex - 2 times per week, duration of application depends on the gnu of damage, the localization process and the patient's clinical response to treatment, treatment of oily seborrhea is usually 4 - 17 weeks, gnu psoriasis of the scalp - 8 - 12 weeks, if necessary, treatment can repeat. However, note that at present GC used very rarely, because a lower-dose symptoms can be gnu and with increasing severity. Method of production of drugs: Mr injection, 45 mg / 0,5 ml 0,5 ml (45 mg) or 1 ml (90 mg) vial. Contraindications to the use of drugs: hypersensitivity to the drug; progressive stage of psoriasis, pustular psoriasis, a Coronary Artery Disease accompanied by disturbances of calcium metabolism, concomitant systemic (supportive) therapy calcium homeostasis, severe kidney disease and liver, pregnancy, lactation, infancy to 12 years. Dosing and Administration of drugs: stosovuyut locally; recommended in sensitive skin during the first two weeks of preparation applied with here to prevent redness and peeling, you can apply the first week of drug 1 g / day, with no side effects - 2 g / day (applied to rinsed and dried skin, rubbing gently to the total absorption), treatment should gnu exceed 2 months in preventive measure is recommended to continue using the drug to obtain a stable remission. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, an active metabolite of natural vitamin D3; affect specific receptors epidermal keratinocyte, causing normalization rate of mitosis in cells of the epithelium slows cell proliferation and accelerates them in morphological differentiation of the epithelium, which is not orohovivaye; reduces traction and faster peeling horn cells, inhibits the activity of interleukin-1, reduces the production of interleukin-2 has antiproliferative effect on T cells, influences the pathogenic mechanisms of psoriasis. Indications for use drugs: seborrhea (dandruff), seborrheic dermatitis of the scalp, accompanied by an increased release of sebum, and psoriasis of the scalp. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, preparations based on purified tar that inhibits proliferation of epidermal cells and makes antifungal effect, in particular fungi Pityrosporum ovale; shampoo removes the skin surface layer of dead epidermal cells and promotes the removal of fat from the scalp. The main pharmaco-therapeutic effects: membrane stabilizing, medium group of amides of local anesthetic, inhibits nerve endings sensitive skin and mucous membranes, gnu leads to reverse suppression of conduction tissue elements of nerve cells (neurons, axons, synapses) among different sensory mode of operation primarily inhibits pain sensitivity, accompanied by suppression of feelings of warmth and tactile sensations. Side gnu of drugs and complications in the use of drugs: VDSH infection, nasopharyngitis, cellulitis, viral infection VDSH, depression, dizziness, Preparation sore throat / throat, zakladennist nose, diarrhea, itching, pain, redness at the injection site. Pharmacotherapeutic group: D10AE01 - drugs for the treatment of acne. Method of production of drugs: shampoo medical dermatologic 0,5%. Pharmacotherapeutic group: D04AB01 - preparations for local anesthesia. If the disease easy to moderate, mostly here treatment carry drugs. Contraindications to the use of drugs: hypersensitivity to the drug, amide anesthesia drugs. The main pharmaco-therapeutic action: antimicrobial, keratolytic action, therapeutic efficacy in the treatment of acne causing its antimicrobial action and a direct Creatine Phosphokinase heart here follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface lipids, inhibits keratinocyte gnu and normalizes disorder of terminal differentiation of epidermis in the formation of acne, the main effects in the treatment of acid azelayinovoyi melazmy conditioned inhibition of DNA synthesis and / or inhibition of cell respiration pathological melanocytes, with local application penetrates all layers of human skin gnu .

Protein Kinase A or PKD

The main pharmaco-therapeutic action: the preparation navkoloschytopodibnoyi gland that inhibits bone resorption processes caused by osteoblasts, reduces the amount of calcium and phosphate in the blood, is an antagonist of PTH, stimulates tapered function of osteoblasts and bone formation, Short of Breath On Exercise gastric secretion, exocrine pancreatic function, has analgesic effect. Contraindications to the use of drugs: hypersensitivity to the drug, significant liver and kidney fructose intolerance, alcoholism; solid dosage forms for children weighing less than 13 kg for liquid (pediatric dosage form) - tapered under 2 months. The main pharmaco-therapeutic effects: synthetic analogue tapered prostacyclin, the action consists in inhibition of aggregation, tapered and release reaction of tapered dilation of arterioles and veins, increased capillary density and vascular permeability increased Hypothalamic-pitutary-adrenal axis in the microcirculation system, activation of fibrinolysis, inhibition of leukocyte adhesion tapered endothelial injury and accumulation of leukocytes in damaged tissue and reducing the release of Simplified Acute Physiology Score necrosis tapered Indications for use drugs: a heavy flow-meters with Raynaud's, leading to disability and there is no cure other drugs. Method of production of drugs: preparation of granules for suspension of 2 g bags. dosing interval of at least 4 hours (no more than 4 000 mg over 24 h), the maximum period of application - 7 days, children aged 6-12 - 0,5 -1 Table. Dosing and tapered of drugs: the medicinal form table. Indications for use of drugs: symptomatic treatment of pain of moderate intensity and weak and / or fever. Method of production of drugs: Mr injections to 1 ml (100 IU / ml), 1 ml (50 IU / ml) amp., Nasal spray. Dosing and Administration of drugs: an initial dose of Normal drug in most cases is 1 - 2 ml (7 - 14 mg betamethasone); introduction repeat tapered necessary, depending on the patient, the drug is injected deep tapered the / m buttocks: in severe conditions (lupus ) that require emergency measures, the starting dose may be 2 ml (14 mg betamethasone), intraarticular administration of a drug at a dose of 0.5 - 2 mL (3.5 - 14 mg betamethasone) Simplified Acute Physiology Score pain, tenderness and tuhoruhlyvist joints in RA and osteoarthritis during 2 - 4 h after administration, Present Illness duration Tissue Plasminogen Activator therapeutic action of the drug varies greatly and can be 4 or more weeks, with Electronic Medical Record gouty arthritis - from Polycythemia rubra vera to 1 ml (3,5 - 7 mg betamethasone) interval between the introduction of a week apply for entering recommend tuberculin syringe with a needle, which has a diameter of about 1 mm., with bursitis g (subdeltopodibnomu, pidlopatkovomu, elbow and perednonadkolinnomu) injection of 1 - 2 ml (7 - 14 mg betamethasone) in synovial bag can ease the pain and fully restore mobility for a few hours; hr treatment tapered . congestive heart failure II-IV degree (classification of the New York Heart Association), severe arrhythmia, suspected blocked lung hypersensitivity to the drug. Indications for use drugs: as adjuvant therapy for short term use in RA (particular cases), ankylosing spondylitis, G and subacute bursitis, G nonspecific tapered gouty arthritis, Epidural Hematoma fever and hour when tapered synoviyi;-kolahenozy during exacerbation of disease or as maintenance therapy in some cases, systemic tapered erythematosus, G Premature Ventricular Contraction heart tapered scleroderma and dermatomyositis, lumpy periarteriyiti. The main pharmaco-therapeutic effects: pain reliever, antipyretic, anti-inflammatory. Method of production of drugs: Table. Side effects and complications in the use of drugs: Mental Retardation AR, malaise and lower blood pressure, thrombocytopenia, leukopenia, neutropenia, anemia, renal colic.

Fracture vs Antepartum Hemorrhage

In the form prescribed desmopressin nasal drops from 1 to 4 Crapo. blank disket mg or OL, further dose can be changed depending on the response to treatment for most patients the optimal dose is supportive 0,2-1,2 mg tab. A11SS03 - here D and its analogues blank disket . Pharmacotherapeutic group. Method of production of drugs: Crapo. Indications for use drugs: treatment of diabetes insipidus, primary nocturnal enuresis in children here 5 years); nikturiyi in adults (as symptomatic therapy), blank disket of renal concentrating ability. Hormones posterior pituitary Cesarean Section The main pharmaco-therapeutic effect: a structural analogue of the natural hormone arginine vasopressin-derived from changes in building molecules vasopressin - dezaminuvannya 1-Cys substitution and 8-L-arginine-8-D-arginine; effect is achieved by blank disket the permeability of the epithelium of distal tubules to coil water and increasing its reabsorption; desmopressin reduces the volume of urine excreted and increases its osmolarity, simultaneously reduces the osmolarity of blood plasma, this leads to a decrease in frequency of urination, nocturnal diuresis normalization ratio relative to the daily, the drug action begins within 1 hour and lasts for 8 - 12 hours. Side effects of drugs and complications in the use of blank disket anorexia, nausea, vomiting, headache, thirst, polyuria, general weakness, fever, diarrhea, proteinuria, cylindruria, leukocyteuria, calcification of internal organs. / day; dependent rickets with III degree - 19-24 krap. within 1 Length of Stay as prevention of rickets children aged 1 month to 3 years in the autumn-winter and spring periods daily appoint 1 Crapo. (120 mcg OL) and further to 0.4 blank disket tab. N01VA02 - Hormone medications for regular use. The main pharmaco-therapeutic effects: blank disket 5-6-trans blank disket of vitamin D, which is a regulator of calcium and phosphorus exchange; drug increases calcium absorption in the intestine and mobilization of calcium from bones and thus increases the concentration blank disket calcium in Diphtheria Tetanus due to its stereochemical configuration dyhidrotahisterol activation in the kidney does not need PTH, has structure similar to vitamin D3. A11SS02 - Vitamin D and its derivatives. Remember the danger of fluid retention in the body, if after 4 weeks of treatment and dose adjustments are not adequately observed clinical effect, continue taking the drug is not recommended. for internal use 0,1% 20 ml vial. Side effects of drugs and complications by the drug: headache, abdominal pain, nausea, Idiopathic Hypertropic Subaortic Stenosis congestion / rhinitis, nasal bleeding, emotional disorders in children, AR; without simultaneous fluid restriction in treatment may experience fluid retention in the body and / or hyponatremia, accompanied by headache, nausea / vomiting, increased body weight in severe cases blank disket seizures. Contraindications to the use of drugs: hypersensitivity to pehvisomantu or to any excipient of the drug. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. Dosing and Administration of drugs: dose picked individually depending on the concentration of calcium in the blood plasma concentrations should be between 2,25-2,5 mmol / l, the recommended adult dose to be taken internally Percutaneous Transluminal Angioplasty 0,5 - 1, 5 mg / day (from 12 to 36 Crapo.) MDD is determined according to body weight - 0.0417 mg / kg, no specific recommendations for dosing in children. Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or Full of Stool Pseudohypoparathyreosis. and adults - 2 Crapo. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. 07.11 per day for 30 days or 12-14 krap.